Effect of patient comorbidities on filling of antihypertensive prescriptions

American Journal of Managed Care

Volumn 15, Issue 1, 2009, Pages 24-30

  Lagu, Tara ^a,c   Weiner, Mark G ^a   Eachus, Susan ^a   Tang, Simon S K ^b   Schwartz, J Sanford ^a   Turner, Barbara J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b PFIZER INC   (United States)

^c BAYSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; THIAZIDE DIURETIC AGENT; VASODILATOR AGENT;

ADULT; ARTICLE; BLOOD PRESSURE; COMORBIDITY; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAID; PATIENT COMPLIANCE; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; AFRICAN AMERICANS; ANTIHYPERTENSIVE AGENTS; COMORBIDITY; CROSS-SECTIONAL STUDIES; ELECTRONIC PRESCRIBING; FEMALE; HUMANS; HYPERTENSION; MALE; MEDICAID; MEDICATION ADHERENCE; MIDDLE AGED; UNITED STATES; YOUNG ADULT;

EID: 58849087184     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report [published correction appears in JAMA. 2003;290(2):197]. JAMA. 2003;289(19):2560-2572.
2. Krousel-Wood M, Thomas S, Muntner P, Morisky D. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol. 2004;19(4):357-362.
3. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43(6):521-530.
4. Wong ND, Lopez VA, L'Italien GL, Chen R, Kline SEJ, Franklin SS. Inadequate control of hypertension in US adults with cardiovascular disease comorbidities. Arch Intern Med. 2007;167(22):2431-2436.
5. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States [published correction appears in N Engl J Med. 2002;346(7):544]. N Engl J Med. 2001;345(7):479-486.
6. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487-497.
7. Higashi T, Shekelle PG, Solomon DH, et al. The quality of pharmacologic care for vulnerable older patients. Ann Intern Med. 2004;140(9):714-720.
8. Schroeder K, Fahey T, Ebrahim S. Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings. Cochrane Database Syst Rev. 2004;(2):CD004804.
9. Hagstrom B, Mattsson B, Rost IM, Gunnarsson RK. What happened to the prescriptions? A single, short, standardized telephone call may increase compliance. Fam Pract. 2004;21(1):46-50.
10. Cooper WO, Hickson GB. Corticosteroid prescription filling for children covered by Medicaid following an emergency department visit or a hospitalization for asthma. Arch Pediatr Adolesc Med. 2001;155(10):1111-1115.
11. Johnson TL, Parker AL. Rates of retrieval of self-injectable epinephrine prescriptions: a descriptive report. Ann Allergy Asthma Immunol. 2006;97(5):694-697.
12. Jones I, Britten N. Why do some patients not cash their prescriptions? Br J Gen Pract. 1998;48(426):903-905.
13. Kirking MH, Zaleon CR, Kirking DM. Unclaimed prescriptions at a university hospital's ambulatory care pharmacy. Am J Health Syst Pharm. 1995;52(5):490-495.
14. Wright H, Forbes D, Graham H. Primary compliance with medication prescribed for paediatric patients discharged from a regional hospital. J Paediatr Child Health. 2003;39(8):611-612.
15. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23(8):1296-1310.
16. Piette JD, Heisler M, Ganoczy D, McCarthy JF, Valenstein M. Differential medication adherence among patients with schizophrenia and comorbid diabetes and hypertension. Psychiatr Serv. 2007;58(2):207-212.
17. Siegel D, Lopez J, Meier J. Antihypertensive medication adherence in the Department of Veterans Affairs. Am J Med. 2007;120(1):26-32.
18. Morris AB, Li J, Kroenke K, Bruner-England TE, Young JM, Murray MD. Factors associated with drug adherence and blood pressure control in patients with hypertension. Pharmacotherapy. 2006;26(4):483-492.
19. Romanelli J, Fauerbach JA, Bush DE, Ziegelstein RC. The significance of depression in older patients after myocardial infarction. J Am Geriatr Soc. 2002;50(5):817-822.
20. Avom J, Monette J, Lacour A, et al. Persistence of use of lipid-lowering medications: a cross-national study. JAMA. 1998;279(18):1458-1462.
21. Chapman RH, Benner JS, Petrilla AA, et al. Predictors of adherence with antihypertensive and lipid-lowering therapy. Arch Intern Med. 2005;165(10):1147-1152.
22. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens. 1997;10(7, pt 1):697-704.
23. Tumer BJ, Hollenbeak CS, Weiner MG, Ten Have T, Tang S. Effect of unrelated comorbid conditions on hypertension management. Ann Intern Med. 2008;148(8):578-586.
24. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [published correction appears in Arch Intern Med. 1998;158(6):573]. Arch Intern Med. 1997;157(21):2413-2446.
25. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-2497.
26. Balkrishnan R. Predictors of medication adherence in the elderly. Clin Ther. 1998;20(4):764-771.
27. Piette JD, Heisler M. The relationship between older adults' knowledge of their drug coverage and medication cost problems. J Am Geriatr Soc. 2006;54(1):91-96.
28. Kennedy J, Coyne J, Sclar D. Drug affordability and prescription noncompliance in the United States: 1997-2002. Clin Ther. 2004;26(4):607-614.
29. Kephart G, Skedgel C, Sketris I, Grootendorst P, Hoar J. Effect of copayments on drug use in the presence of annual payment limits. Am J Manag Care. 2007;13(6, pt 2):328-334.
30. Zeber JE, Grazier KL, Valenstein M, Blow FC, Lantz PM. Effect of a medication copayment increase in veterans with schizophrenia. Am J Manag Care. 2007;13(6, pt 2):335-346.
31. Goldman DP, Joyce GF, Zheng Y. Prescription drug cost sharing: associations with medication and medical utilization and spending and health. JAMA. 2007;298(1):61-69.
32. Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avom J. Long-term persistence in use of statin therapy in elderly patients. JAMA. 2002;288(4):455-461.
33. Kerr EA, Heisler M, Krein SL, et al. Beyond comorbidity counts: how do comorbidity type and severity influence diabetes patients' treatment priorities and self-management? J Gen Intern Med. 2007;22(12):1635-1640.
34. Taira DA, Gelber RP, Davis J, Gronley K, Chung RS, Seto TB. Antihypertensive adherence and drug class among Asian Pacific Americans. Ethn Health. 2007;12(3):265-281.
35. Brookhart MA, Patrick AR, Dormuth C, et al. Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect. Am J Epidemiol. 2007;166(3):348-354.
36. Glynn RJ, Schneeweiss S, Wang PS, Levin R, Avorn J. Selective prescribing led to overestimation of the benefits of lipid-lowering drugs. J Clin Epidemiol. 2006;59(8):819-828.